These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20632397)

  • 61. Physicochemical and Biopharmaceutical Controllability of New Self-Assembled Fatty Acid Conjugated Leuprolide for the Enhanced Anticancer Activity.
    Ngo HV; Bak HE; Nguyen HD; Lee KW; Park C; Lee BJ
    Int J Nanomedicine; 2023; 18():2325-2344. PubMed ID: 37168738
    [TBL] [Abstract][Full Text] [Related]  

  • 62. GPCR Modulation in Breast Cancer.
    Lappano R; Jacquot Y; Maggiolini M
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513833
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.
    Sable R; Durek T; Taneja V; Craik DJ; Pallerla S; Gauthier T; Jois S
    ACS Chem Biol; 2016 Aug; 11(8):2366-74. PubMed ID: 27337048
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rational Design of a Dephosphorylation-Resistant Reporter Enables Single-Cell Measurement of Tyrosine Kinase Activity.
    Turner AH; Lebhar MS; Proctor A; Wang Q; Lawrence DS; Allbritton NL
    ACS Chem Biol; 2016 Feb; 11(2):355-62. PubMed ID: 26587880
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of cell adhesion and immune responses in the mouse model of collagen-induced arthritis with a peptidomimetic that blocks CD2-CD58 interface interactions.
    Gokhale AS; Sable R; Walker JD; McLaughlin L; Kousoulas KG; Jois SD
    Biopolymers; 2015 Nov; 104(6):733-42. PubMed ID: 26031942
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone Analogs.
    Moradi SV; Varamini P; Toth I
    AAPS J; 2015 Sep; 17(5):1135-43. PubMed ID: 25956382
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The low-energy conformations of gonadotropin-releasing hormone in aqueous solution.
    Pincus MR; Woo J; Monaco R; Lubowsky J; Avitable MJ; Carty RP
    Protein J; 2014 Dec; 33(6):565-74. PubMed ID: 25404067
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low energy conformations for gonadotropin-releasing hormone with D- and L-amino acid substitutions for Gly 6: possible receptor-bound conformations.
    Pincus MR; Woo J; Monaco R; Lubowsky J; Carty RP
    Protein J; 2014 Dec; 33(6):575-87. PubMed ID: 25399235
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of a peptidase-resistant substrate for single-cell measurement of protein kinase B activation.
    Proctor A; Wang Q; Lawrence DS; Allbritton NL
    Anal Chem; 2012 Aug; 84(16):7195-202. PubMed ID: 22881604
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Metabolism of peptide reporters in cell lysates and single cells.
    Proctor A; Wang Q; Lawrence DS; Allbritton NL
    Analyst; 2012 Jul; 137(13):3028-38. PubMed ID: 22314840
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
    Teplán I
    Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs.
    Pappa EV; Zompra AA; Spyranti Z; Diamantopoulou Z; Pairas G; Lamari FN; Katsoris P; Spyroulias GA; Cordopatis P
    Biopolymers; 2011; 96(3):260-72. PubMed ID: 20632397
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structural elucidation of Leuprolide and its analogues in solution: insight into their bioactive conformation.
    Laimou DK; Katsara M; Matsoukas MT; Apostolopoulos V; Troganis AN; Tselios TV
    Amino Acids; 2010 Nov; 39(5):1147-60. PubMed ID: 20354741
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancer.
    Katsila T; Balafas E; Liapakis G; Limonta P; Montagnani Marelli M; Gkountelias K; Tselios T; Kostomitsopoulos N; Matsoukas J; Tamvakopoulos C
    J Pharmacol Exp Ther; 2011 Mar; 336(3):613-23. PubMed ID: 21106905
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
    Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
    Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.